공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 단일클론항체 시장(2021-2027년) : 시장 예측(종류, 용도, 최종사용자별), COVID-19의 영향, 지역적 전망, 용도 잠재성, 시장 점유율

Monoclonal Antibodies Market Size By Type, By Application, By End-use, COVID19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 - 2027

리서치사 Global Market Insights Inc.
발행일 2021년 06월 상품 코드 1009051
페이지 정보 영문 150 Pages
가격
US $ 5,150 ₩ 5,899,000 Unprintable PDF (Single User License)
US $ 7,150 ₩ 8,190,000 Printable PDF (Multi User License)
US $ 9,150 ₩ 10,481,000 Printable PDF (Enterprise User License)


세계의 단일클론항체 시장(2021-2027년) : 시장 예측(종류, 용도, 최종사용자별), COVID-19의 영향, 지역적 전망, 용도 잠재성, 시장 점유율 Monoclonal Antibodies Market Size By Type, By Application, By End-use, COVID19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 - 2027
발행일 : 2021년 06월 페이지 정보 : 영문 150 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

단일클론항체 시장은 2027년까지 상당한 성장을 나타낼 것으로 예측됩니다.

선진 국가를 중심으로 한 첨단 치료법에 대한 인식 확산, 특정 인공 항체를 개발하기 위한 첨단 기술 이용, 전문 센터 확대 등의 요인이 시장 성장을 추진하고 있습니다.

세계의 단일클론항체(Monoclonal Antibodies) 시장을 조사했으며, 시장 정의와 개요, 신종 코로나바이러스 감염증(COVID-19) 및 기타 시장 영향요인 분석, 규제 상황, 시장 규모 추정과 예측, 종류·용도·최종사용자·지역/주요 국가 등 각종 세분화별 내역, 경쟁 상황, 주요 기업 개요 등을 정리했습니다.

제1장 조사 방법

제2장 주요 요약

제3장 산업 분석

  • 산업 분류
  • 산업 상황
  • 산업에 대한 영향요인
    • 성장 촉진요인
    • 잠재적 위험과 과제
  • 성장 잠재성
  • 규제 상황
  • 단일클론항체 치료의 향후 동향
  • Porter's Five Forces 분석
  • 경쟁 상황
  • PESTEL 분석

제4장 시장 분석과 예측 : 종류별

  • 완전 인간형
  • 인간화형
  • 키메라형
  • 기타

제5장 시장 분석과 예측 : 용도별

  • 종양
  • 자가면역질환
  • 감염증
  • 기타

제6장 시장 분석과 예측 : 최종사용자별

  • 병원
  • 클리닉
  • 기타

제7장 시장 분석과 예측 : 지역·주요 국가별

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제8장 기업 개요

  • 경쟁 대시보드
  • F Hoffmann-La Roche Ltd
  • AbbVie Inc
  • Amgen
  • Bristol Myers Squibb
  • Johnson & Johnson
  • Merck & Co , Inc
  • Regeneron Pharmaceuticals Inc.
  • Novartis AG
  • AstraZeneca
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Takeda Pharmaceuticals
KSM 21.06.11

Data Tables

  • TABLE 1. Monoclonal antibodies market, 2016 - 2020 (USD Million)
  • TABLE 2. Monoclonal antibodies market, 2021 - 2027(USD Million)
  • TABLE 3. Monoclonal antibodies market, by type, 2016 - 2020 (USD Million)
  • TABLE 4. Monoclonal antibodies market, by type, 2021 - 2027 (USD Million)
  • TABLE 5. Monoclonal antibodies market, by application, 2016 - 2020 (USD Million)
  • TABLE 6. Monoclonal antibodies market, by application, 2021 - 2027(USD Million)
  • TABLE 7. Monoclonal antibodies market, by end-use, 2016 - 2020 (USD Million)
  • TABLE 8. Monoclonal antibodies market, by end-use, 2021 - 2027(USD Million)
  • TABLE 9. Monoclonal antibodies market, by region, 2016 - 2020 (USD Million)
  • TABLE 10. Monoclonal antibodies market, by region, 2021 - 2027(USD Million)
  • TABLE 11. Industry impact forces
  • TABLE 12. Fully human market size, by region, 2016 - 2020 (USD Million)
  • TABLE 13. Fully human market size, by region, 2021 - 2027(USD Million)
  • TABLE 14. Humanized market size, by region, 2016 - 2020 (USD Million)
  • TABLE 15. Humanized market size, by region, 2021 - 2027(USD Million)
  • TABLE 16. Chimeric market size, by region, 2016 - 2020 (USD Million)
  • TABLE 17. Chimeric market size, by region, 2021 - 2027(USD Million)
  • TABLE 18. Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 19. Others market size, by region, 2021 - 2027(USD Million)
  • TABLE 20. Oncology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 21. Oncology market size, by region, 2021 - 2027(USD Million)
  • TABLE 22. Autoimmune diseases market size, by region, 2016 - 2020 (USD Million)
  • TABLE 23. Autoimmune diseases market size, by region, 2021 - 2027(USD Million)
  • TABLE 24. Infectious diseases market size, by region, 2016 - 2020 (USD Million)
  • TABLE 25. Infectious diseases market size, by region, 2021 - 2027(USD Million)
  • TABLE 26. Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 27. Others market size, by region, 2021 - 2027(USD Million)
  • TABLE 28. Hospitals market size, by region, 2016 - 2020 (USD Million)
  • TABLE 29. Hospitals market size, by region, 2021 - 2027(USD Million)
  • TABLE 30. Clinics market size, by region, 2016 - 2020 (USD Million)
  • TABLE 31. Clinics market size, by region, 2021 - 2027(USD Million)
  • TABLE 32. Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 33. Others market size, by region, 2021 - 2027(USD Million)
  • TABLE 34. North America monoclonal antibodies market size, by country, 2016 - 2020 (USD Million)
  • TABLE 35. North America monoclonal antibodies market size, by country, 2021 - 2027 (USD Million)
  • TABLE 36. North America monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 37. North America monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 38. North America monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 39. North America monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 40. North America monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 41. North America monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 42. U.S. monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 43. U.S. monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 44. U.S. monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 45. U.S. monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 46. U.S. monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 47. U.S. monoclonal antibodies market size, by End-use, 2021 - 2027 (USD Million)
  • TABLE 48. Canada monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 49. Canada monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 50. Canada monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 51. Canada monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 52. Canada monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 53. Canada monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 54. Europe monoclonal antibodies market size, by country, 2016 - 2020 (USD Million)
  • TABLE 55. Europe monoclonal antibodies market size, by country, 2021 - 2027 (USD Million)
  • TABLE 56. Europe monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 57. Europe monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 58. Europe monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 59. Europe monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 60. Europe monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 61. Europe monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 62. Germany monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 63. Germany monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 64. Germany monoclonal antibodies market size, by application, type - 2020 (USD Million)
  • TABLE 65. Germany monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 66. Germany monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 67. Germany monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 68. UK monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 69. UK monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 70. UK monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 71. UK monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 72. UK monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 73. UK monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 74. France monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 75. France monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 76. France monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 77. France monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 78. France monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 79. France monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 80. Spain monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 81. Spain monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 82. Spain monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 83. Spain monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 84. Spain monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 85. Spain monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 86. Italy monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 87. Italy monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 88. Italy monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 89. Italy monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 90. Italy monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 91. Italy monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 92. Asia Pacific monoclonal antibodies market size, by country, 2016 - 2020 (USD Million)
  • TABLE 93. Asia Pacific monoclonal antibodies market size, by country, 2021 - 2027 (USD Million)
  • TABLE 94. Asia Pacific monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 95. Asia Pacific monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 96. Asia Pacific monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 97. Asia Pacific monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 98. Asia Pacific monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 99. Asia Pacific monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 100. Japan monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 101. Japan monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 102. Japan monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 103. Japan monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 104. Japan monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 105. Japan monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 106. China monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 107. China monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 108. China monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 109. China monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 110. China monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 111. China monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 112. India monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 113. India monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 114. India monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 115. India monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 116. India monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 117. India monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 118. Australia monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 119. Australia monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 120. Australia monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 121. Australia monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 122. Australia monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 123. Australia monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 124. Latin America monoclonal antibodies market size, by country, 2016 - 2020 (USD Million)
  • TABLE 125. Latin America monoclonal antibodies market size, by country, 2021 - 2027 (USD Million)
  • TABLE 126. Latin America monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 127. Latin America monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 128. Latin America monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 129. Latin America monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 130. Latin America monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 131. Latin America monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 132. Brazil monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 133. Brazil monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 134. Brazil monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 135. Brazil monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 136. Brazil monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 137. Brazil monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 138. Mexico monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 139. Mexico monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 140. Mexico monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 141. Mexico monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 142. Mexico monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 143. Mexico monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 144. Argentina monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 145. Argentina monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 146. Argentina monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 147. Argentina monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 148. Argentina monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 149. Argentina monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 150. MEA monoclonal antibodies market size, by country, 2016 - 2020 (USD Million)
  • TABLE 151. MEA monoclonal antibodies market size, by country, 2021 - 2027 (USD Million)
  • TABLE 152. MEA monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 153. MEA monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 154. MEA monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 155. MEA monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 156. MEA monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 157. MEA monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 158. South Africa monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 159. South Africa monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 160. South Africa monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 161. South Africa monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 162. South Africa monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 163. South Africa monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 164. Saudi Arabia monoclonal antibodies market size, by type, 2016 - 2020 (USD Million)
  • TABLE 165. Saudi Arabia monoclonal antibodies market size, by type, 2021 - 2027 (USD Million)
  • TABLE 166. Saudi Arabia monoclonal antibodies market size, by application, 2016 - 2020 (USD Million)
  • TABLE 167. Saudi Arabia monoclonal antibodies market size, by application, 2021 - 2027 (USD Million)
  • TABLE 168. Saudi Arabia monoclonal antibodies market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 169. Saudi Arabia monoclonal antibodies market size, by end-use, 2021 - 2027 (USD Million)

Charts & Figures

  • FIG. 1 Monoclonal antibodies industry 360 degree synopsis
  • FIG. 2 Industry segmentation
  • FIG. 3 Global monoclonal antibodies market, 2016 - 2027 (USD Million)
  • FIG. 4 Growth potential analysis, by type
  • FIG. 5 Growth potential analysis, by application
  • FIG. 6 Growth potential analysis, by end-use
  • FIG. 7 Porter's analysis
  • FIG. 8 Company share analysis, 2020
  • FIG. 9 Brand analysis
  • FIG. 10 PESTEL analysis
  • FIG. 11 Key segment trends, by type
  • FIG. 12 Key segment trends, by application
  • FIG. 13 Key segment trends, by end-use
  • FIG. 14 Key segment trends, by region
  • FIG. 15 Competitive dashboard, 2020

The monoclonal antibodies market is poised to amass noteworthy gains over 2021-2027 owing to the increasing awareness regarding advanced therapies, use of advanced technologies for development of specific artificial antibodies, and expansion of specialty centers, particularly in developed countries. Antibodies are basically proteins which are used by the immune system to identify as well as neutralize foreign bodies, like viruses, bacteria, or tumor cells.

Monoclonal antibodies (mAb) are laboratory-made proteins that imitate the ability of the immune system to fight off harmful pathogens like viruses. For example, etesevimab and bamlanivimab are mAbs which are precisely directed against the spike protein of SARS-CoV-2, designed to block the attachment of the virus as well as entry into human cells.

Different types of monoclonal antibodies could be generated in the laboratory to identify, while binding to the particular antigen of interest. The monoclonal antibodies industry is bifurcated into several segments on the basis of type, application, end-use and regional landscape.

With respect to type, the market for monoclonal antibodies is classified into chimeric, humanized, fully human, and others. In 2020, the market share from other mAb types was valued at more than $9 billion and is anticipated to register consistent growth in the years to come. Use of advanced technologies for development of specific artificial antibodies will offer growth opportunities for monoclonal antibodies market players. Mouse monoclonal antibodies comprises of 100 per cent mouse-derived proteins.

Talking of application, the market is categorized into infectious diseases, autoimmune diseases, oncology and others. The other applications segment is anticipated to showcase a CAGR of over 14.2% through 2027. Development activities and number of potential products for emerging therapies including transplant rejection and migraine will drive mAb market forecast.

Monoclonal antibodies are also used in the treatment of numerous inflammatory and allergic diseases as well as cancers. mAbs are useful to treat a few of the cancer types. Till now, the United States FDA has approved approximately a dozen monoclonal antibodies, for example trastuzumab and alemtuzumab, to treat cancers.

In terms of end-use, the monoclonal antibodies market is segmented into clinics, hospitals and others. In 2020, the other users segment was valued at $55 billion and will witness robust growth over the coming years. Facility expansion of specialty centers in developed countries to cater to the increasing number of people suffering from various diseases will drive mAb industry trends .

On the geographical front, the Middle East & Africa monoclonal antibodies market is projected to show around 12% CAGR through 2027. Increasing awareness regarding advanced treatment options and product approvals across different countries will foster the regional growth.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates and working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East & Africa
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Monoclonal antibodies industry 360 degree synopsis
    • 2.1.1 Business trends
    • 2.1.2 Type trends
    • 2.1.3 Application trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Monoclonal antibodies Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing prevalence of chronic and infectious diseases worldwide
      • 3.3.1.2 Growing research and development activities
      • 3.3.1.3 High rate of adoption and approval in the U and Europe
      • 3.3.1.4 Booming biologics market
      • 3.3.1.5 Rising applications of monoclonal antibodies
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 High cost of some monoclonal antibody therapeutics
      • 3.3.2.2 Stringent regulatory framework
  • 3.4 Growth potential analysis
    • 3.4.1 By type
    • 3.4.2 By application
    • 3.4.3 By end-use
  • 3.5 Regulatory landscape
  • 3.6 Future trends in monoclonal antibody-based therapeutics
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2020
    • 3.8.1 Company matrix analysis, 2020
    • 3.8.2 Brand analysis
  • 3.9 PESTEL analysis

Chapter 4 Monoclonal Antibodies Market, By Type

  • 4.1 Key segment trends
  • 4.2 Fully human
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Humanized
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.4 Chimeric
    • 4.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.5 Others
    • 4.5.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Monoclonal Antibodies Market, By Application

  • 5.1 Key segment trends
  • 5.2 Oncology
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Autoimmune diseases
    • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.4 Infectious diseases
    • 5.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.5 Others
    • 5.5.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Monoclonal Antibodies Market, By End-use

  • 6.1 Key segment trends
  • 6.2 Hospitals
    • 6.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.3 Clinics
    • 6.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.4 Others
    • 6.4.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 7 Monoclonal Antibodies Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2016 - 2027 (USD Mn)
    • 7.2.2 Market size, by type, 2016 - 2027 (USD Mn)
    • 7.2.3 Market size, by application, 2016 - 2027 (USD Mn)
    • 7.2.4 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.2.5.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.2.5.3 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.2.6.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.2.6.3 Market size, by end-use, 2016 - 2027 (USD Mn)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2016 - 2027 (USD Mn)
    • 7.3.2 Market size, by type, 2016 - 2027 (USD Mn)
    • 7.3.3 Market size, by application, 2016 - 2027 (USD Mn)
    • 7.3.4 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.3.5.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.3.5.3 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.3.6.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.3.6.3 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.3.7 France
      • 7.3.7.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.3.7.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.3.7.3 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.3.8.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.3.8.3 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.3.9 Spain
      • 7.3.9.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.3.9.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.3.9.3 Market size, by end-use, 2016 - 2027 (USD Mn)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2016 - 2027 (USD Mn)
    • 7.4.2 Market size, by type, 2016 - 2027 (USD Mn)
    • 7.4.3 Market size, by application, 2016 - 2027 (USD Mn)
    • 7.4.4 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.4.5 China
      • 7.4.5.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.4.5.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.4.5.3 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.4.6.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.4.6.3 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.4.7 India
      • 7.4.7.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.4.7.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.4.7.3 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.4.8 Australia
      • 7.4.8.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.4.8.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.4.8.3 Market size, by end-use, 2016 - 2027 (USD Mn)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2016 - 2027 (USD Mn)
    • 7.5.2 Market size, by type, 2016 - 2027 (USD Mn)
    • 7.5.3 Market size, by application, 2016 - 2027 (USD Mn)
    • 7.5.4 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.5.5.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.5.5.3 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.5.6.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.5.6.3 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.5.7.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.5.7.3 Market size, by end-use, 2016 - 2027 (USD Mn)
  • 7.6 MEA
    • 7.6.1 Market size, by country, 2016 - 2027 (USD Mn)
    • 7.6.2 Market size, by type, 2016 - 2027 (USD Mn)
    • 7.6.3 Market size, by application, 2016 - 2027 (USD Mn)
    • 7.6.4 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.6.5.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.6.5.3 Market size, by end-use, 2016 - 2027 (USD Mn)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by type, 2016 - 2027 (USD Mn)
      • 7.6.6.2 Market size, by application, 2016 - 2027 (USD Mn)
      • 7.6.6.3 Market size, by end-use, 2016 - 2027 (USD Mn)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2020
  • 8.2 F Hoffmann-La Roche Ltd
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 AbbVie Inc
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Amgen
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Bristol Myers Squibb
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Johnson & Johnson
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 Merck & Co , Inc
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Regeneron Pharmaceuticals Inc.
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Novartis AG
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 AstraZeneca
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 Eli Lilly and Company
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 GlaxoSmithKline plc
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 Takeda Pharmaceuticals
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis
Back to Top
전화 문의
F A Q